
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Breast Cancer Treatments: Updates and New Challenges
Anna Burguin, Caroline Diorio, Francine Durocher
Journal of Personalized Medicine (2021) Vol. 11, Iss. 8, pp. 808-808
Open Access | Times Cited: 263
Anna Burguin, Caroline Diorio, Francine Durocher
Journal of Personalized Medicine (2021) Vol. 11, Iss. 8, pp. 808-808
Open Access | Times Cited: 263
Showing 1-25 of 263 citing articles:
Breast cancer heterogeneity and its implication in personalized precision therapy
Liantao Guo, Deguang Kong, Jianhua Liu, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 137
Liantao Guo, Deguang Kong, Jianhua Liu, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 137
Galangin/β-Cyclodextrin Inclusion Complex as a Drug-Delivery System for Improved Solubility and Biocompatibility in Breast Cancer Treatment
Zainab S. Abbas, Ghassan M. Sulaiman, Majid S. Jabir, et al.
Molecules (2022) Vol. 27, Iss. 14, pp. 4521-4521
Open Access | Times Cited: 69
Zainab S. Abbas, Ghassan M. Sulaiman, Majid S. Jabir, et al.
Molecules (2022) Vol. 27, Iss. 14, pp. 4521-4521
Open Access | Times Cited: 69
European cancer mortality predictions for the year 2024 with focus on colorectal cancer
Claudia Santucci, Silvia Mignozzi, Matteo Malvezzi, et al.
Annals of Oncology (2024) Vol. 35, Iss. 3, pp. 308-316
Open Access | Times Cited: 45
Claudia Santucci, Silvia Mignozzi, Matteo Malvezzi, et al.
Annals of Oncology (2024) Vol. 35, Iss. 3, pp. 308-316
Open Access | Times Cited: 45
Targeting Breast Cancer: An Overlook on Current Strategies
Domenico Iacopetta, Jessica Ceramella, Noemi Baldino, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3643-3643
Open Access | Times Cited: 40
Domenico Iacopetta, Jessica Ceramella, Noemi Baldino, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3643-3643
Open Access | Times Cited: 40
Emerging role of ferroptosis in breast cancer: New dawn for overcoming tumor progression
Shiyao Sui, Shouping Xu, Da Pang
Pharmacology & Therapeutics (2021) Vol. 232, pp. 107992-107992
Closed Access | Times Cited: 78
Shiyao Sui, Shouping Xu, Da Pang
Pharmacology & Therapeutics (2021) Vol. 232, pp. 107992-107992
Closed Access | Times Cited: 78
Phytochemical-Loaded Liposomes for Anticancer Therapy: An Updated Review
Vivek P. Chavda, Disha R. Vihol, Bhavya Mehta, et al.
Nanomedicine (2022) Vol. 17, Iss. 8, pp. 547-568
Open Access | Times Cited: 62
Vivek P. Chavda, Disha R. Vihol, Bhavya Mehta, et al.
Nanomedicine (2022) Vol. 17, Iss. 8, pp. 547-568
Open Access | Times Cited: 62
Characteristics, Clinical Differences and Outcomes of Breast Cancer Patients with Negative or Low HER2 Expression
C Rosso, Ioannis A. Voutsadakis
Clinical Breast Cancer (2022) Vol. 22, Iss. 4, pp. 391-397
Closed Access | Times Cited: 46
C Rosso, Ioannis A. Voutsadakis
Clinical Breast Cancer (2022) Vol. 22, Iss. 4, pp. 391-397
Closed Access | Times Cited: 46
The role of microRNA-185 in the pathogenesis of human diseases: A focus on cancer
Safoora Pordel, Motahare Khorrami, Fatemeh Saadatpour, et al.
Pathology - Research and Practice (2023) Vol. 249, pp. 154729-154729
Open Access | Times Cited: 30
Safoora Pordel, Motahare Khorrami, Fatemeh Saadatpour, et al.
Pathology - Research and Practice (2023) Vol. 249, pp. 154729-154729
Open Access | Times Cited: 30
The potential role of nanomedicine in the treatment of breast cancer to overcome the obstacles of current therapies
Fan Yang, Qingjie He, Xiangpeng Dai, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 24
Fan Yang, Qingjie He, Xiangpeng Dai, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 24
Injectable Nano-in-Gel Vaccine for Spatial and Temporal Control of Vaccine Kinetics and Breast Cancer Postsurgical Therapy
Taiyuan Liu, Xinghui Si, Liping Liu, et al.
ACS Nano (2024) Vol. 18, Iss. 4, pp. 3087-3100
Closed Access | Times Cited: 13
Taiyuan Liu, Xinghui Si, Liping Liu, et al.
ACS Nano (2024) Vol. 18, Iss. 4, pp. 3087-3100
Closed Access | Times Cited: 13
Unveiling the potential of ursolic acid modified hyaluronate nanoparticles for combination drug therapy in triple negative breast cancer
Reena Sharma, Vivek R. Yadav, Shikha Jha, et al.
Carbohydrate Polymers (2024) Vol. 338, pp. 122196-122196
Closed Access | Times Cited: 10
Reena Sharma, Vivek R. Yadav, Shikha Jha, et al.
Carbohydrate Polymers (2024) Vol. 338, pp. 122196-122196
Closed Access | Times Cited: 10
Recent advancements in nanomaterial-based biosensors for diagnosis of breast cancer: a comprehensive review
Yalda Yazdani, Fereshtehsadat Jalali, Habib Tahmasbi, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Yalda Yazdani, Fereshtehsadat Jalali, Habib Tahmasbi, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
PSMA Radioligand Uptake as a Biomarker of Neoangiogenesis in Solid Tumours: Diagnostic or Theragnostic Factor?
Alessio Rizzo, Sara Dall’Armellina, Daniele Antonio Pizzuto, et al.
Cancers (2022) Vol. 14, Iss. 16, pp. 4039-4039
Open Access | Times Cited: 35
Alessio Rizzo, Sara Dall’Armellina, Daniele Antonio Pizzuto, et al.
Cancers (2022) Vol. 14, Iss. 16, pp. 4039-4039
Open Access | Times Cited: 35
Synergistic Regulation of Targeted Organelles in Tumor Cells to Promote Photothermal‐Immunotherapy Using Intelligent Core‐Satellite‐Like Nanoparticles for Effective Treatment of Breast Cancer
X.-B. Chang, Xiaoyu Tang, Wenjun Tang, et al.
Small (2024) Vol. 20, Iss. 35
Closed Access | Times Cited: 7
X.-B. Chang, Xiaoyu Tang, Wenjun Tang, et al.
Small (2024) Vol. 20, Iss. 35
Closed Access | Times Cited: 7
Intratumoral delivery of immunotherapy to treat breast cancer: current development in clinical and preclinical studies
Siena M. Mantooth, Yara Abdou, Ana Rosa Saez-Ibañez, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Siena M. Mantooth, Yara Abdou, Ana Rosa Saez-Ibañez, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Correlations of Imaging and Therapy in Breast Cancer Based on Molecular Patterns: An Important Issue in the Diagnosis of Breast Cancer
Oana Maria Burciu, Ioan Sas, Tudor-Alexandru Popoiu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8506-8506
Open Access | Times Cited: 7
Oana Maria Burciu, Ioan Sas, Tudor-Alexandru Popoiu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8506-8506
Open Access | Times Cited: 7
Natural Compounds for Preventing Age-Related Diseases and Cancers
Mi‐Ran Ki, Sol Youn, Dong Hyun Kim, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7530-7530
Open Access | Times Cited: 6
Mi‐Ran Ki, Sol Youn, Dong Hyun Kim, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7530-7530
Open Access | Times Cited: 6
Targeted Therapies and Drug Resistance in Advanced Breast Cancer, Alternative Strategies and the Way beyond
Andrea Nicolini, Paola Ferrari
Cancers (2024) Vol. 16, Iss. 2, pp. 466-466
Open Access | Times Cited: 5
Andrea Nicolini, Paola Ferrari
Cancers (2024) Vol. 16, Iss. 2, pp. 466-466
Open Access | Times Cited: 5
Potential therapeutic targets of the JAK2/STAT3 signaling pathway in triple-negative breast cancer
Long Lin, Xiangyu Fei, Liucui Chen, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 5
Long Lin, Xiangyu Fei, Liucui Chen, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 5
Specific microbiome patterns and their association with breast cancer: the intestinal microbiota as a potential biomarker and therapeutic strategy
Alba Amaro-da-Cruz, Teresa Rubio‐Tomás, Ana I. Álvarez‐Mercado
Clinical & Translational Oncology (2024)
Open Access | Times Cited: 5
Alba Amaro-da-Cruz, Teresa Rubio‐Tomás, Ana I. Álvarez‐Mercado
Clinical & Translational Oncology (2024)
Open Access | Times Cited: 5
Ethnobotanical survey of medicinal plants used in management of Breast cancers in Qatar
Rasha S.Abo El Alaa, Hend Al-Jaber, Fatima Al Zahraa Chokor, et al.
Heliyon (2025) Vol. 11, Iss. 4, pp. e42541-e42541
Open Access
Rasha S.Abo El Alaa, Hend Al-Jaber, Fatima Al Zahraa Chokor, et al.
Heliyon (2025) Vol. 11, Iss. 4, pp. e42541-e42541
Open Access
Enhancing breast cancer treatment: Evaluating the efficacy of hyaluronic acid-coated tamoxifen-loaded solid lipid nanoparticles on MCF7 cells
Niloufar Ghayoumipour, Hossein Ghafouri
Human & Experimental Toxicology (2025) Vol. 44
Open Access
Niloufar Ghayoumipour, Hossein Ghafouri
Human & Experimental Toxicology (2025) Vol. 44
Open Access
Enhanced prediction of radiation-induced skin toxicity in breast cancer patients using a hybrid dosiomics-clinical model
Samira Soltani, A Aliasgharzadeh, Pedram Fadavi, et al.
Journal of Radiation Research and Applied Sciences (2025) Vol. 18, Iss. 2, pp. 101382-101382
Closed Access
Samira Soltani, A Aliasgharzadeh, Pedram Fadavi, et al.
Journal of Radiation Research and Applied Sciences (2025) Vol. 18, Iss. 2, pp. 101382-101382
Closed Access
Biomimetic Nanoparticles: A Revolutionary Approach to Breast Cancer Therapy Using Cell Membrane Coatings
Jyoti Chandra, Nagashekhara Molugulu, Garima Gupta, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106849-106849
Closed Access
Jyoti Chandra, Nagashekhara Molugulu, Garima Gupta, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106849-106849
Closed Access
Roles of HLA-G/KIR2DL4 in Breast Cancer Immune Microenvironment
Guoxu Zheng, Lintao Jia, Angang Yang
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 24
Guoxu Zheng, Lintao Jia, Angang Yang
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 24